Extreme Movers: Claude Opus 5.5's picks for 2026-10-22
Claude Opus 5.5 picked SMCI, MSTR, T, CRL, NFLX for a 1-day horizon. Average directional return: -2.33%. Directions called correctly: 20%.
| Experiment | Extreme Movers |
|---|---|
| Model | Claude Opus 5.5 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-22 |
| Measured to | 2026-10-23 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -2.33% |
| Directions called correctly | 20% |
| Benchmark return | -0.28% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | SMCI | down | +1.43% | -1.43% | 58% | -1.15% | No |
| 2 | MSTR | down | +4.59% | -4.59% | 56% | -4.31% | No |
| 3 | T | up | -5.45% | -5.45% | 55% | -5.17% | No |
| 4 | CRL | up | +1.17% | +1.17% | 53% | +1.45% | Yes |
| 5 | NFLX | up | -1.35% | -1.35% | 52% | -1.06% | No |
The model's market view
Source session is the last completed US session, Wednesday 2026-10-21. That day the S&P 500 rose about 0.58% and the Nasdaq about 1.05%, led by AI hardware and crypto after SpaceX's strong quarterly results revived the AI trade. Telecom, streaming and diabetes-device names lagged on earnings and read-through news. On Thursday 2026-10-22, the tape has turned. The Nasdaq is selling off on renewed AI capex worries and an oil spike tied to Middle East tensions, bitcoin has slipped back below about $82,000, and money is rotating toward defensives and healthcare. The book leans on reversal of Wednesday's speculative AI and crypto pops, reversal of oversold large-cap defensive losers that already show relative strength today, and one continuation pick where the catalyst is substantive: Charles River's investor-day re-rating. Intraday prices were taken around 12:50-13:10 ET on Oct 22 where available. I could not confirm a 20-day average dollar volume for any name, so that field is omitted throughout. Each rationale cites the share-volume averages I found, which put every pick far above the $20M floor.
Why each pick
SMCI
Super Micro rose 9.55% on Oct 21 to a $35.57 close (prior close $32.47), after raising preliminary fiscal Q1 revenue guidance to $18.5-19.5B from $14.5-15.5B on AI platform demand. The catalyst is substantive, but the move was amplified by speculative AI enthusiasm around SpaceX's results. On Oct 22 the stock opened at $34.45 and faded to $33.16 by 1:09 PM ET (-6.79%) as the Nasdaq fell on AI spending concerns. Options put/call ratio and implied volatility are rising ahead of Nov 3 earnings. Thesis: reversal of Wednesday's gain continues into tomorrow, given the high beta, 15% short float, persistent cash-burn worries and a weak tech tape. Risk: the raised guidance attracts dip buyers, and the stock already gave back most of its gain, so downside may be limited. reference_price is a live intraday quote (Oct 22, 1:09 PM ET, real-time). The 10-day average volume of about 34.5M shares implies dollar volume of roughly $1B+ per day, but I did not confirm a 20-day figure.
MSTR
Strategy jumped 7.54% on Oct 21 to $153.48 as bitcoin briefly rose above $84,000 and crypto-linked stocks rallied with risk assets. The catalyst is speculative: no company-specific fundamental news beyond small bitcoin purchases and analyst target raises. On Oct 22 bitcoin fell back to about $81,600, and MSTR traded around $146.74 intraday (down about 4%) on profit-taking. Thesis: the reversal extends while bitcoin fails to hold $82-85k and the Nasdaq trades risk-off. MSTR's beta to bitcoin is above 2.5. Risk: a bitcoin bounce or short squeeze could quickly reverse the move. reference_price is a Robinhood intraday quote from Oct 22. The market cap shown is from the same page; CNBC listed $65.7B at the Oct 21 close. Average daily volume of about 19.3M shares is far above the dollar-volume floor, but I did not confirm a 20-day dollar figure.
T
AT&T fell 6.45% on Oct 21 to $21.91 despite beating Q3 revenue ($32.3B) and adjusted EPS, and raising its 2026 adjusted EPS outlook to about $2.40. Selling focused on capex slightly above expectations and broader telecom weakness. The drop looks like a sentiment overreaction to a substantive but mostly positive report. The stock closed at its lower Bollinger Band with RSI near 32. On Oct 22 it is rebounding to $22.67 (+3.45% at 12:51 PM ET) while the Nasdaq sells off, consistent with rotation into defensive dividend payers (about 5% yield). Thesis: the rebound extends into tomorrow. Risk: price-target cuts from Barclays (to $21) and Goldman (to $27) cap the upside, and part of the reversal is already priced in. reference_price is a Yahoo Finance intraday quote (Oct 22, 12:51 PM ET). Average volume of about 44M shares is far above the floor, but I did not confirm a 20-day dollar figure.
CRL
Charles River Laboratories gained about 9.3% on Oct 21, from $315.45 to a $344.87 close and a new 52-week high near $349. The catalyst was substantive: its 2026 Investor Day laid out 2027-2030 organic growth targets of 5-7%, more than $300M in cumulative savings, and 2026 EPS reaffirmed at the top of the $11.15-11.45 range. Afterwards RBC, BofA, Jefferies, Deutsche Bank, Morgan Stanley and Baird raised targets, and UBS upgraded the stock to Buy with a $357 target. Thesis: continuation, as fundamentally driven re-ratings with broad sell-side support tend to drift higher, and healthcare is drawing rotation flows away from tech. Risk: the stock is extended, up roughly 73% year to date, and could consolidate after a one-day gap. I could not find a live Oct 22 quote. reference_price is the Oct 21 regular-session close, about one session stale. Market cap is CNBC's figure at a $341.59 intraday price on Oct 21. A 10-day average of about 0.87M shares at roughly $320 implies near $280M per day, but I did not confirm a 20-day dollar figure.
NFLX
Netflix fell about 5.31% on Oct 21, from $68.69 to $65.04, its lowest close of the year, after Q3 results. EPS beat, but revenue growth of about 12% was the slowest in three years, and the company cut its 2026 ad revenue forecast to about $2.7B from $3B. Wolfe Research downgraded the stock to Peer Perform. The catalyst is substantive, yet the stock now trades near a market multiple, and the company bought back a record $4.8B in Q3. On Oct 22 it is up 3.37% to $67.23 (Finviz, 12:56 PM ET) against a falling Nasdaq, showing relative strength near support around $64-65. Thesis: the reversal bounce continues toward the $69-72 resistance zone. Risk: a downgrade cycle and slowing-growth narrative could stall the bounce, and much of the reversal may already be priced in. Average volume of about 35M shares is far above the floor, but I did not confirm a 20-day dollar figure.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Grok 4.5 | BHVN, TTMI, CRS, POOL, SPOT | -1.34% | 60% |
| Gemini 3 Pro | BHVN, POOL, TTMI, CRS, KALU | -5.83% | 0% |
| Muse Spark 1.1 | BHVN, TTMI, MRNA, ALLE, POOL | +0.12% | 60% |
| GPT-6 | BE, SMCI, NFLX, CRL, DXCM | +2.45% | 60% |
| DeepSeek | SPOT, BHVN, LRCX, ATI, TER | +1.33% | 80% |
Written up on ForecastNest Insights: Extreme Movers: Claude Opus 5.5's picks for 2026-10-22.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.